TY - JOUR
T1 - Investigation of the Biocompatibility and Osteogenic Effects of Magnesium-doped Chloride-containing Bioactive Glasses
AU - Ouyang, Zechi
AU - Li, Piao
AU - Ru, Xiaomei
AU - Liu, Linghao
AU - Shah, Priyen
AU - Liu, Ousheng
AU - Hill, Robert
AU - Chen, Xiaohui
AU - Chen, Xiaojing
PY - 2025/1/25
Y1 - 2025/1/25
N2 - Bioactive glass (BG) degrades in vivo, releasing therapeutic ions and forming an apatite-like phase to repair hard tissues. Many BG derived materials have been employed clinically; however researchers continue to work on improving the physicochemical properties and biological functions of BG due to their inappropriate degradation rate and unsatisfactory bone repair effects. Our previous work revealed that the incorporation of chlorine (Cl) into BG expanded the glass structure, facilitating glass degradation and a rapid hydroxyapatite (HAP) formation. Chloride-containing bioactive glasses (GPCl) showed good osteogenesis effects in vitro and in vivo. However, the fast degradation rate of GPCl may cause a mismatch between bone formation and glass degradation, limiting its bone repair efficacy. In this study, we incorporated various amounts of magnesium (0-20 mol%) into GPCl to regulate its degradation behavior and enhance its bone regeneration ability. Four glasses were synthesized using a melt-quench method. The in vitro glass bioactivity was evaluated in α-MEM, while the in vivo osteogenic effect of the Mg-doped chloride-containing BGs (GPMgCl) was investigated on a rat skull critical-size defect and compared with the commercially available bone substitute (Bio-Oss®). Additionally, the blood and main organs of rats were collected to assess the biocompatibility of GPMgCl. Our results demonstrated that the Mg delayed the degradation rate of GPCl and the rate of HAP formation while maintaining an excellent bioactivity in α-MEM. GPMgCl promoted the expression of OCN, BMP2, and VEGF, and facilitated the formation of the mineralized nodules. Moreover, GPMgCl exhibited superior osteogenic effects compared to Bio-Oss® in vivo, with GPMg10Cl showing the optimal bone regeneration ability. Blood biochemical analyses, blood cell tests and hematoxylin-eosin (HE) staining of organs confirmed the excellent biocompatibility of GPMgCl. Incorporating Mg into GPCl is a promising approach to regulate degradation behavior and enhance osteogenic performance, making GPMgCl a promising bone substitute material to meet future bone repair needs.
AB - Bioactive glass (BG) degrades in vivo, releasing therapeutic ions and forming an apatite-like phase to repair hard tissues. Many BG derived materials have been employed clinically; however researchers continue to work on improving the physicochemical properties and biological functions of BG due to their inappropriate degradation rate and unsatisfactory bone repair effects. Our previous work revealed that the incorporation of chlorine (Cl) into BG expanded the glass structure, facilitating glass degradation and a rapid hydroxyapatite (HAP) formation. Chloride-containing bioactive glasses (GPCl) showed good osteogenesis effects in vitro and in vivo. However, the fast degradation rate of GPCl may cause a mismatch between bone formation and glass degradation, limiting its bone repair efficacy. In this study, we incorporated various amounts of magnesium (0-20 mol%) into GPCl to regulate its degradation behavior and enhance its bone regeneration ability. Four glasses were synthesized using a melt-quench method. The in vitro glass bioactivity was evaluated in α-MEM, while the in vivo osteogenic effect of the Mg-doped chloride-containing BGs (GPMgCl) was investigated on a rat skull critical-size defect and compared with the commercially available bone substitute (Bio-Oss®). Additionally, the blood and main organs of rats were collected to assess the biocompatibility of GPMgCl. Our results demonstrated that the Mg delayed the degradation rate of GPCl and the rate of HAP formation while maintaining an excellent bioactivity in α-MEM. GPMgCl promoted the expression of OCN, BMP2, and VEGF, and facilitated the formation of the mineralized nodules. Moreover, GPMgCl exhibited superior osteogenic effects compared to Bio-Oss® in vivo, with GPMg10Cl showing the optimal bone regeneration ability. Blood biochemical analyses, blood cell tests and hematoxylin-eosin (HE) staining of organs confirmed the excellent biocompatibility of GPMgCl. Incorporating Mg into GPCl is a promising approach to regulate degradation behavior and enhance osteogenic performance, making GPMgCl a promising bone substitute material to meet future bone repair needs.
U2 - 10.20517/microstructures.2024.54
DO - 10.20517/microstructures.2024.54
M3 - Article
SN - 0026-2846
VL - 5
JO - Microstructures
JF - Microstructures
M1 - 2025013
ER -